Opening Blood-Brain Barrier to Deliver Alzheimer’s Drug Shows Promise
Aducanumab (Aduhelm) infusions combined with focused ultrasound led to lower cerebral amyloid-beta levels in Alzheimer's disease, a proof-of-concept trial showed. ...
Read moreDetails
